| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 妇科及计生用药(元) | 718,181,135.11 | 386,750,695.59 | 810,842,768.56 | 418,424,516.42 |
| 麻醉及肌松用药(元) | 217,132,019.28 | 125,449,484.32 | 252,489,533.52 | 129,573,898.43 |
| 皮质激素(元) | 2,513,493,331.15 | 1,184,877,005.64 | 2,512,337,217.27 | 1,233,732,668.28 |
| 其他(元) | 310,162,679.88 | 172,150,189.99 | 425,023,628.70 | 356,116,526.70 |
| 营业成本(元) | ||||
| 妇科及计生用药(元) | 227,278,261.91 | 130,471,222.21 | 304,284,488.41 | 155,209,244.44 |
| 麻醉及肌松用药(元) | 85,725,867.15 | 43,617,249.69 | 66,945,407.54 | 33,666,796.24 |
| 皮质激素(元) | 976,522,768.38 | 458,702,055.58 | 1,068,340,962.78 | 520,355,637.91 |
| 其他(元) | 169,441,057.49 | 55,823,241.67 | 261,271,700.51 | 256,166,164.50 |
| 毛利(元) | ||||
| 妇科及计生用药(元) | 490,902,873.20 | 256,279,473.38 | 506,558,280.15 | 263,215,271.98 |
| 麻醉及肌松用药(元) | 131,406,152.13 | 81,832,234.63 | 185,544,125.98 | 95,907,102.19 |
| 皮质激素(元) | 1,536,970,562.77 | 726,174,950.06 | 1,443,996,254.49 | 713,377,030.37 |
| 其他(元) | 140,721,622.39 | 116,326,948.32 | 163,751,928.19 | 99,950,362.20 |
| 毛利率(%) | ||||
| 妇科及计生用药(%) | 68.35 | 66.26 | 62.47 | 62.91 |
| 麻醉及肌松用药(%) | 60.52 | 65.23 | 73.49 | 74.02 |
| 皮质激素(%) | 61.15 | 61.29 | 57.48 | 57.82 |
| 其他(%) | 45.37 | 67.57 | 38.53 | 28.07 |
| 收入构成(%) | ||||
| 妇科及计生用药(%) | 19.11 | 20.69 | 20.27 | 19.57 |
| 麻醉及肌松用药(%) | 5.78 | 6.71 | 6.31 | 6.06 |
| 皮质激素(%) | 66.87 | 63.39 | 62.80 | 57.71 |
| 其他(%) | 8.25 | 9.21 | 10.62 | 16.66 |
| 毛利构成(%) | ||||
| 妇科及计生用药(%) | 21.34 | 21.71 | 22.03 | 22.45 |
| 麻醉及肌松用药(%) | 5.71 | 6.93 | 8.07 | 8.18 |
| 皮质激素(%) | 66.82 | 61.51 | 62.79 | 60.84 |
| 其他(%) | 6.12 | 9.85 | 7.12 | 8.52 |